Evidence map›Paper›PMID 39351181›Full record

ArticlePlastic and reconstructive surgery. Global open2024

Outcomes of Xenograft with Platelet-rich Fibrin versus Autogenous Bone in Alveolar Cleft Grafting.

Hager Montaser Bedeer, Awny Asklany, Wagdi M Ali, Mohamed Elyounsi, Mohamed Nahed Attia Mohammed, Mostafa Mahmoud Youssef, Mohamed El-Shazly

Abstract read
In one paragraph

Article in Plastic and reconstructive surgery. Global open, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Hager Montaser BedeerFrom the Plastic and Reconstructive Surgery Department, Assiut University Hospital, Assiut, Egypt.
Awny AsklanyFrom the Plastic and Reconstructive Surgery Department, Assiut University Hospital, Assiut, Egypt.
Wagdi M AliFrom the Plastic and Reconstructive Surgery Department, Assiut University Hospital, Assiut, Egypt.
Mohamed ElyounsiFrom the Plastic and Reconstructive Surgery Department, Assiut University Hospital, Assiut, Egypt.
Mohamed Nahed Attia MohammedOral and Maxillofacial Surgery Department, Faculty of Dentistry, Assiut University Hospital, Assiut, Egypt.
Mostafa Mahmoud YoussefOral and Maxillofacial Radiology Department, Faculty of Dentistry, Assiut University Hospital, Assiut, Egypt.
Mohamed El-ShazlyFrom the Plastic and Reconstructive Surgery Department, Assiut University Hospital, Assiut, Egypt.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: The use of a suitable graft material helps with sufficient osseointegration. The aim of this study was to compare the clinical and radiographic outcomes of two types of alveolar bone graft materials, xenografts with platelet-rich fibrin (PRF) and autogenous grafts, in patients with alveolar clefts. Methods: Thirty-six patients with alveolar clefts were enrolled in this study. Those patients were randomly divided into two groups: group A, where the autogenous iliac bone graft was used to fill the alveolar defect, and group B, where the xenograft with PRF was used to fill the alveolar defect. After 6 months of grafting, patients were assessed in terms of pain, duration of hospital stay, and donor site morbidity associated with iliac crest harvesting, while bone formation was evaluated radiographically using cone beam computed tomography. Results: The results showed no statistical differences as regards baseline and perioperative data. Operative duration was significantly lower among xenograft with PRF patients. Both groups had comparable postoperative success scores, and total failure was reported in a total of three patients (one patient in group A and two patients in group B). Conclusions: With no potential donor site morbidities, xenograft with PRF is an equivalent bone transplant replacement to the autologous iliac bone graft. Additionally, it is associated with a significant success rate, and a significant decrease in operative time and hospital stay. Many future studies are warranted to draw firm conclusions.

Identifiers

PMID39351181
PMCPMC11441918

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.